Device Trial Radar · NCT02995421
Transcutaneous Electrical Stimulation for Stress Urinary Incontinence
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
23
Actual
Start
Dec 2016
Primary completion
Aug 2018
Study completion Aug 2018
Sponsor
- Lead sponsor
- Elidah, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 16, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates surface electrical muscle stimulation for women with incontinence symptoms. Phase I is a single-session study to test usability, comfort and tolerability at various waveforms. Phase II is a six-week at-home study to test compliance and efficacy.
Conditions
- Stress Urinary Incontinence
- Urinary Incontinence
Interventions
Surface electrodeDevice
Transcutaneous electrical stimulation with various waveforms
Primary outcomes
What the sponsor says the trial is designed to measure.
- Questionnaire on comfort and tolerabilityTime frame: 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
At-Home
Monroe, Connecticut
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.